1. Short title This Act may be cited as the Childhood Cancer Clinical Trials Act . 2. Amendments relating to coverage in individual and group market and under Medicare program for qualified individuals diagnosed with a rare pediatric disease participating in approved clinical trials (a) Individual and group market (1) Requiring out-of-network coverage of routine patient costs Section 2709 of the Public Health Service Act ( 42 U.S.C. 300gg–8 ) is amended— (A) in subsection (a)(2)— (i) in subparagraph (A), by inserting and subsection (c)(2) after (1)(B) ; and (ii) in subparagraph (B), by inserting and subsection (c)(2) after (1)(B) ; (B) by amending subsection (c) to read as follows: (c) Treatment of non-Participating providers (1) In general Subject to paragraph (2), this section shall not be construed to require a group health plan, or a health insurance issuer offering group or individual health insurance coverage, to provide benefits for routine patient care services provided outside of the plan's (or coverage's) health care provider network unless out-of-network benefits are otherwise provided under the plan (or coverage). (2) Qualified individuals diagnosed with a rare pediatric disease In the case of a qualified individual diagnosed with a rare pediatric disease, with respect to routine patient costs for items and services furnished to such individual in connection with participation in an approved clinical trial by a nonparticipating provider, a group health plan or health insurance issuer offering group or individual health insurance coverage that provides coverage to such individual— (A) shall impose the same cost-sharing requirement (expressed as a copayment amount or coinsurance rate) that would apply if such item or service was furnished by a participating provider; and (B) shall pay to such nonparticipating provider the amount by which the recognized amount for such item or service exceeds the cost-sharing amount for such item or service (as determined in accordance with subparagraph (A)).